# Use of Nile Tilapia Fish Skin as a Xenograft for Burn Treatment: Phase III Study

> **NCT04202289** · PHASE3 · COMPLETED · sponsor: **Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara** · enrollment: 115 (actual)

## Conditions studied

- Burns

## Interventions

- **DEVICE:** Nile Tilapia Fish Skin
- **DRUG:** Silver Sulfadiazine Cream 1%

## Key facts

- **NCT ID:** NCT04202289
- **Lead sponsor:** Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-03
- **Primary completion:** 2018-10-24
- **Final completion:** 2018-10-24
- **Target enrollment:** 115 (ACTUAL)
- **Last updated:** 2020-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04202289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04202289, "Use of Nile Tilapia Fish Skin as a Xenograft for Burn Treatment: Phase III Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04202289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*